| ID | Analyse ▼ | Domein | Recipiënt | Uitvoering | LTAT (uren (dagen)) | Accred. | LOINCeenheid (1) | LOINCeenheid (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 71085 | Selderij f85 IgG | Serum |
2× per week, op dinsdag en vrijdag | – | 60363-9 mgA/l | – | › | |||
| 21190 | Sedimentatie na 1 uur Bezinkingssnelheid, Erythrocytensedimentatie, ESR | EDTA |
maandag t/m vrijdag | 1 (0) | B | 4537-7 mm | – | › | ||
| 52790 | sDMA s-dimethylarginine | Serum |
3× per week | 111 (4,6) | B | 90781-6 µg/l | 80981-4 µg/dl | › | ||
| 29695 | Screening MSSA Screening Methicilline Sensibele Staphylococcus Aureus | eSwab |
– | – | – | › | ||||
| 29668 | Screening MRSA: andere | eSwab |
45 (1,9) | – | – | – | › | |||
| 29658 | Screening MRSA perianaal | eSwab |
44 (1,8) | B | – | – | › | |||
| 29657 | Screening MRSA neus | eSwab |
44 (1,9) | B | 52969-3 | – | › | |||
| 29659 | Screening MRSA keel | eSwab |
43 (1,8) | B | 76081-9 | – | › | |||
| 29663 | Screening ESBL perianaal Screening Extended-Spectrum Bèta-Lactamase perianaal | eSwab |
42 (1,7) | – | – | – | › | |||
| 29689 | Screening ESBL neus Screening Extended-Spectrum Bèta-Lactamase neus | eSwab |
46 (1,9) | – | – | – | › | |||
| 29662 | Screening ESBL keel Screening Extended-Spectrum Bèta-Lactamase keel | eSwab |
90 (3,7) | – | – | – | › | |||
| 29660 | Screening ESBL Screening Extended-Spectrum Bèta-Lactamase andere | eSwab |
38 (1,6) | – | – | – | › | |||
| 75544 | Screening Candida auris B | eSwab |
– | – | – | › | ||||
| 75543 | Screening Candida auris | eSwab |
– | – | – | › | ||||
| 71254 | Schol f254 IgG | Serum |
2× per week, op dinsdag en vrijdag | – | – mgA/l | – | › | |||
| 4333 | Schistosoma serologie Bilharziasis | Serum |
154 (6,4) | – | 6629-0 | – | › | |||
| 29710 | Schimmels:huid,haar,nagel Dermatofytose, Dermatophytose, Fungi | eSwab (Wissers varia / Overig) |
862 (35,9) | – | – | – | › | |||
| 29690 | Schimmels: andere Kultuur schimmels (andere) | eSwab (Wissers varia / Overig) |
301 (12,6) | – | – | – | › | |||
| 75535 | Schimmels(huid/nagel) Dermatofytose, Dermatophytose, Fungi | eSwab (Wissers varia / Overig) |
868 (36,2) | – | 51723-5 | – | › | |||
| 71088 | Schapenvlees f88 IgG | Serum |
2× per week, op dinsdag en vrijdag | – | – mgA/l | – | › | |||
| 4872 | SCC Ag SCC Ag | Serum |
2× per week, op dinsdag en vrijdag | 86 (3,6) | – | 9679-2 µg/L | – | › | ||
| 4882 | SCC Ag SCC Ag | Serum |
2× per week, op dinsdag en vrijdag | 61 (2,5) | – | 9679-2 µg/L | – | › | ||
| 24589 | SARS-CoV-2-S antistoffen Coronavirus 19, COVID-19, Severe Acute Respiratory Syndrome | Serum |
maandag t/m vrijdag | 24 (1) | – | 94505-5 U/mL | – | › | ||
| 24645 | SARS-CoV-2-N-IgG/IgM Coronavirus 19, COVID-19, Severe Acute Respiratory Syndrome | Serum |
maandag t/m vrijdag | 68 (2,8) | – | – COI | – | › | ||
| 71061 | Sardien f61 IgG | Serum |
2× per week, op dinsdag en vrijdag | – | 63134-1 mgA/l | – | › | |||
| 4540 | Salmonella PCR | Faeces |
291 (12,1) | – | – | – | › | |||
| 24110 | Salmonella (Widal) Widal | Serum |
6 (0,2) | – | 98211-6 | – | › | |||
| 55660 | Salicylzuur Acenterine, Acetylsalicylzuur, Aspirine | Serum |
bij ontvangst van het staal | 167 (6,9) | – | 3306-8 mg/dl | 14909-6 µmol/L | › | ||
| 57988 | Salicylaten | Urine |
167 (6,9) | – | 4026-1 mg/dL | – | › | |||
| 8556 | Sabino 1 | EDTA |
– | – | – | › | ||||
| 4942 | S100 | Serum |
tenminste 2× per week | 41 (1,7) | – | 83114-9 µg/L | – | › | ||
| 23232 | S.cerevisiae IgG (ASCA) Anti-Saccharomyces cerevisiae antistoffen | Serum |
maandag t/m vrijdag | 13 (0,5) | – | 6713-2 U/ml | – | › | ||
| 7776 | S-Phenylmercaptaanzuur S-Fenylmercaptaanzuur, S-Phenylmercaptuurzuur, S-PMA | Urine |
141 (5,9) | – | – | – | › | |||
| 8220 | S-Methylcysteine | Urine |
– | – | – | › | ||||
| 71315 | Ruwe berk t3 IgG | Serum |
2× per week, op dinsdag en vrijdag | 111 (4,6) | – | – mgA/l | – | › | ||
| 57476 | Ruthenium /g creatinine | Urine |
282 (11,7) | – | – | – | › | |||
| 71027 | Rundvlees f27 IgG | Serum |
2× per week, op dinsdag en vrijdag | – | – mgA/l | – | › | |||
| 24546 | Rubella IgM | Serum |
maandag t/m vrijdag | 1 (0,1) | B | 8015-0 Index | – | › | ||
| 24547 | Rubella IgG vrouw | Serum |
maandag t/m vrijdag | 1 (0,1) | B | 8014-3 IU/mL | – | › | ||
| 24574 | Rubella bevestiging | Serum |
20 (0,8) | – | – | – | › | |||
| 29292 | RSV antigeen | Aspiraat (nasopharynx) |
maandag t/m vrijdag | 2 (0,1) | – | – | – | › | ||
| 4511 | RSB Bovine Respiratoir Syncytieel Virus, BRSV | Serum |
– | – | – | › | ||||
| 28302 | Rotavirus Ag Rota antigeen | Faeces |
maandag t/m vrijdag | 64 (2,6) | B | 17547-1 | – | › | ||
| 8519 | Rotavirus (A) | Faeces |
– | – | – | › | ||||
| 71005 | Rogge f5 IgG | Serum |
2× per week, op dinsdag en vrijdag | 108 (4,5) | – | 51933-0 mgA/l | – | › | ||
| 26554 | Rode bloedcellen | Urine |
maandag t/m zaterdag | 3 (0,1) | B | 798-9 /µl | – | › | ||
| 23193 | Ro52/TRIM21 Anti-RO, Anti-Sjögren's syndrome A ab | Serum |
maandag t/m vrijdag | 6 (0,2) | – | 82933-3 AU/mL | – | › | ||
| 69862 | Rkn.pt.fRhD genotypering | EDTA |
172 (7,2) | – | – | – | › | |||
| 6122 | Risperidone 9-hydroxyrisperidon, 9-hydroxyrisperidone, Invega | Serum |
128 (5,3) | – | – | – | › | |||
| 34383 | Risico pre-eclampsie EPE | Serum |
95 (4) | – | – | – | › |
